Table 3 Leukapheresis in pregnancy:... | American Society of Hematology

Table 3

Leukapheresis in pregnancy: outcome of patients at Hammersmith Hospital

CML individual pregnancy managed by leukapheresis	WCC at diagnosis, ×10⁹/L	Leukapheresis regimen	Other treatment	Duration of pregnancy,* wk	Live infant
		1-2 weekly until 26-30 wk, n = 7	None, n = 10		Live infant, n = 11


N = 12⁶⁵	25-240 (90)	1-4 × wk, n = 1	HU from 30 wk, n = 1	35-40 (39)	Live infant, meningomyelocele and talipes,† n = 1
		1-4 × wk, n = 1	HU from 30 wk, n = 1		Live infant, meningomyelocele and talipes,† n = 1
		2-3 × wk, n = 4	Aspirin and LMWH, n = 1
		2-3 × wk, n = 4	Aspirin and LMWH, n = 1

CML individual pregnancy managed by leukapheresis	WCC at diagnosis, ×10⁹/L	Leukapheresis regimen	Other treatment	Duration of pregnancy,* wk	Live infant
		1-2 weekly until 26-30 wk, n = 7	None, n = 10		Live infant, n = 11


N = 12⁶⁵	25-240 (90)	1-4 × wk, n = 1	HU from 30 wk, n = 1	35-40 (39)	Live infant, meningomyelocele and talipes,† n = 1
		1-4 × wk, n = 1	HU from 30 wk, n = 1		Live infant, meningomyelocele and talipes,† n = 1
		2-3 × wk, n = 4	Aspirin and LMWH, n = 1
		2-3 × wk, n = 4	Aspirin and LMWH, n = 1

HU, hydroxyurea; LMWH, low-molecular-weight heparin; WCC, white cell count.

Data not known in 1 case.

Treatment with leukapheresis only.